{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:05:40Z","timestamp":1762459540909,"version":"3.37.3"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tara Leah Witmer Memorial Foundation, PA"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181529","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T18:29:09Z","timestamp":1515176949000},"page":"e0181529","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0405-9424","authenticated-orcid":true,"given":"A. B.","family":"Madhankumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver D.","family":"Mrowczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Becky","family":"Slagle-Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vagisha","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre J.","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly S.","family":"Harbaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/cncr.22533","article-title":"Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1","volume":"109","author":"A Ferrari","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3340\/jkns.2013.53.3.190","article-title":"Malignant peripheral nerve sheath tumor of non-neurofibromatosis type I metastasized to the cerebrospinal axis","volume":"53","author":"MK Park","year":"2013","journal-title":"J Korean Neurosurg Soc"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3988\/jcn.2012.8.1.75","article-title":"Malignant nerve sheath tumor of the spinal accessory nerve: a unique presentation of a rare tumor","volume":"8","author":"OA Sheikh","year":"2012","journal-title":"J Clin Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1746-1596-5-2","article-title":"Malignant peripheral nerve sheath tumor associated with neurofibromatosis type 1, with metastasis to the heart: a case report","volume":"5","author":"M Kitamura","year":"2010","journal-title":"Diagn Pathol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.surneu.2006.10.033","article-title":"Metastasizing malignant peripheral nerve sheath tumor initially presenting as intracerebral hemorrhage. Case report and review of the literature","volume":"68","author":"SK Park","year":"2007","journal-title":"Surg Neurol"},{"key":"ref6","first-page":"26","article-title":"Malignant peripheral nerve sheath tumour of the oesophagus Review of the literature and report of a case with lymph node and distant metastases","volume":"88","author":"VK Mavroeidis","year":"2017","journal-title":"Ann Ital Chir"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1586\/14737175.5.4.515","article-title":"Diagnosis and treatment options for nerve sheath tumors","volume":"5","author":"JH Huang","year":"2005","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective","volume":"6","author":"RE Ferner","year":"2007","journal-title":"Lancet Neurol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/annonc\/mdq338","article-title":"First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study","volume":"22","author":"JR Kroep","year":"2011","journal-title":"Ann Oncol"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s12094-010-0494-8","article-title":"Primary intracranial malignant peripheral nerve sheath tumour responding to chemotherapy","volume":"12","author":"F Zambrana","year":"2010","journal-title":"Clin Transl Oncol"},{"issue":"30","key":"ref11","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1073\/pnas.1511759112","article-title":"Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance","volume":"112","author":"K Masui","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref12","first-page":"985","article-title":"Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas","volume":"5","author":"W Debinski","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/sj.neo.7900234","article-title":"IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13","volume":"4","author":"A Mintz","year":"2002","journal-title":"Neoplasia"},{"issue":"22","key":"ref14","doi-asserted-by":"crossref","first-page":"8678","DOI":"10.1158\/0008-5472.CAN-09-2100","article-title":"A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis","volume":"69","author":"T Fujisawa","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00432-009-0724-z","article-title":"Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer","volume":"136","author":"L Hou","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1A","key":"ref16","first-page":"125","article-title":"Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4","volume":"19","author":"M Kornmann","year":"1999","journal-title":"Anticancer Res"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/cncr.22134","article-title":"Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy","volume":"107","author":"M Kioi","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11060-012-0998-x","article-title":"Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy","volume":"111","author":"JT Yeung","year":"2013","journal-title":"J Neurooncol"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1158\/1535-7163.MCT-10-1064","article-title":"Silencing IL-13Ralpha2 promotes glioblastoma cell death via endogenous signaling","volume":"10","author":"LC Hsi","year":"2011","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ijc.26366","article-title":"IL-13 regulates cancer invasion and metastasis through IL-13Ralpha2 via ERK\/AP-1 pathway in mouse model of human ovarian cancer","volume":"131","author":"T Fujisawa","year":"2012","journal-title":"Int J Cancer"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/BF03401786","article-title":"Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer\/testis antigen","volume":"6","author":"W Debinski","year":"2000","journal-title":"Mol Med"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/1535-7163.MCT-08-0853","article-title":"Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model","volume":"8","author":"AB Madhankumar","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/1535-7163.MCT-06-0480","article-title":"Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme","volume":"5","author":"AB Madhankumar","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"ref24","unstructured":"A.B.Madhankumar H, K., Slagle-Webb, B., Pang, M., Connor, JR. Targeted Liposomal Doxorubicin as Potential Therapy for Malignant Peripheral Nerve Sheath Tumor. Neuro-Oncology-Abstract from Society for Neuro-oncology Annual Meeting. 2009;11(5):591."},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"A.B.Madhankumar S-W, B., Park, A., Klinger, M., Pang, M., Harbaugh, K., Sheehan, J., Connor, JR. IL13 Linked Liposomal Doxorubicin for Peripheral Nerve Sheath Tumors. Cancer Research- Abstract from Annual Meeting for Cancer Research. 2010;70(8):AM10-5521.","DOI":"10.1158\/1538-7445.AM10-5521"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4161\/cbt.10.1.11993","article-title":"Bioluminescent imaging study: FAK inhibitor, PF-562,271, preclinical study in PC3M-luc-C6 local implant and metastasis xenograft models","volume":"10","author":"H Sun","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2144\/03355rr02","article-title":"Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging","volume":"35","author":"G Choy","year":"2003","journal-title":"Biotechniques"},{"issue":"1 Suppl","key":"ref28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2144\/000112515","article-title":"Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals","volume":"43","author":"CP Klerk","year":"2007","journal-title":"Biotechniques"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1227\/01.NEU.0000195114.24819.4F","article-title":"Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect","volume":"58","author":"O Szentirmai","year":"2006","journal-title":"Neurosurgery"},{"issue":"49","key":"ref30","article-title":"Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents","author":"AN Turk","year":"2011","journal-title":"J Vis Exp"},{"issue":"13","key":"ref31","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1096\/fj.06-5995fje","article-title":"N-linked glycosylation of IL-13R alpha2 is essential for optimal IL-13 inhibitory activity","volume":"20","author":"M Kioi","year":"2006","journal-title":"FASEB J"},{"issue":"3","key":"ref32","first-page":"481","article-title":"Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme","volume":"15","author":"W Debinski","year":"1999","journal-title":"Int J Oncol"},{"issue":"17","key":"ref33","first-page":"6381","article-title":"Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker","volume":"9","author":"M Kawakami","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"16","key":"ref34","first-page":"6194","article-title":"Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer","volume":"61","author":"K Kawakami","year":"2001","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"ref35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF02700026","article-title":"Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma","volume":"64","author":"A Mintz","year":"2003","journal-title":"J Neurooncol"},{"issue":"31","key":"ref36","doi-asserted-by":"crossref","first-page":"49281","DOI":"10.18632\/oncotarget.10297","article-title":"Interleukin-13 receptor alpha2 is associated with poor prognosis in patients with gastric cancer after gastrectomy","volume":"7","author":"C Lin","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/0008-5472.CAN-11-4090","article-title":"High expression of IL-13 receptor alpha2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis","volume":"72","author":"R Barderas","year":"2012","journal-title":"Cancer Res"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1607-551X(09)70233-5","article-title":"Immunoprofiles in malignant peripheral nerve sheath tumor: three case reports and literature review","volume":"22","author":"SW Hu","year":"2006","journal-title":"Kaohsiung J Med Sci"},{"issue":"4","key":"ref39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s100249900138","article-title":"p53 and Ki-67 proliferating cell nuclear antigen in benign and malignant peripheral nerve sheath tumors in children","volume":"2","author":"H Liapis","year":"1999","journal-title":"Pediatr Dev Pathol"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00203733","article-title":"Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours","volume":"427","author":"LG Kindblom","year":"1995","journal-title":"Virchows Arch"},{"issue":"3C","key":"ref41","first-page":"2273","article-title":"A case of malignant schwannoma with overexpression of multidrug resistance gene (MDR1) after chemotherapy","volume":"17","author":"R Suto","year":"1997","journal-title":"Anticancer Res"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/COC.0b013e3181e9c08a","article-title":"Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy","volume":"34","author":"VM Moretti","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"ref43","first-page":"705345","article-title":"Advanced epithelioid malignant peripheral nerve sheath tumor showing complete response to combined surgery and chemotherapy: a case report","volume":"2011","author":"T Minagawa","year":"2011","journal-title":"Case Rep Oncol Med"},{"issue":"7","key":"ref44","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0959-8049(01)00050-8","article-title":"Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL\/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group","volume":"37","author":"I Judson","year":"2001","journal-title":"Eur J Cancer"},{"issue":"16","key":"ref45","first-page":"3569","article-title":"Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype","volume":"55","author":"N Yan","year":"1995","journal-title":"Cancer Res"},{"issue":"12","key":"ref46","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1158\/0008-5472.CAN-08-4475","article-title":"Human schwannomas express activated platelet-derived growth factor receptors and c-kit and are growth inhibited by Gleevec (Imatinib Mesylate)","volume":"69","author":"J Mukherjee","year":"2009","journal-title":"Cancer Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T09:15:28Z","timestamp":1719738928000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181529"}},"subtitle":[],"editor":[{"given":"Jian-Xin","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181529","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}